New Research: THC and CBD May Bring Fast Relief During Migraine Attacks

A clinical trial found that inhaled THC and CBD relieved acute migraine better than placebo, while CBD on its own did not. Here is how the study worked.
Woman sitting on a sofa holding her head with her hand during a migraine
Contents

A clinical trial from the University of California San Diego has examined whether inhaled cannabis can relieve acute migraine attacks. The results suggest that a combination of THC and CBD gave better pain relief than placebo two hours after treatment, and that for many participants the effect lasted one to two days.

Update 2026: When we first wrote about the study, it was only available as a preprint, a version not yet reviewed by other researchers. In February 2026 the final version was published in the scientific journal Headache. It also shows that CBD on its own was no better than placebo.

At a glance

  • The study was randomised, double-blind and placebo-controlled with a crossover design.
  • 92 adults with migraine took part and treated a total of 247 migraine attacks.
  • The combination of 6% THC and 11% CBD gave more pain relief than placebo after two hours.
  • CBD alone (11%) showed no clear difference from placebo.
  • No serious side effects were reported, but larger studies are needed.

How the study worked

Participants treated up to four separate migraine attacks, at least one week apart. For each attack they inhaled vaporised cannabis flower of one of four types, in random order: THC-dominant (6% THC), CBD-dominant (11% CBD), a combination (6% THC and 11% CBD) or placebo. Neither the participants nor the researchers knew which type was used on which occasion.

The researchers mainly measured pain relief two hours after treatment. They also looked at whether participants became completely pain-free and whether their most bothersome symptom went away, such as sensitivity to light, sensitivity to sound or nausea.

Results after two hours

  • Pain relief: 67.2% with THC and CBD, compared with 46.6% with placebo.
  • Completely pain-free: 34.5% with THC and CBD, compared with 15.5% with placebo.
  • Most bothersome symptom gone: 60.3% with THC and CBD, compared with 34.5% with placebo.

With the combination, freedom from pain was still there after 24 hours, and freedom from the most bothersome symptom lasted at both 24 and 48 hours. The THC-dominant type gave more pain relief than placebo but did not make more people completely pain-free. The CBD-dominant type did not differ from placebo on any of the main measures.

What do the results mean?

The study is one of the first randomised trials of cannabis for acute migraine, and its placebo-controlled, double-blind design makes the results more reliable than earlier survey studies. At the same time, it is fairly small, and each participant treated only one attack per type.

The fact that the combination worked better than THC or CBD alone is sometimes seen as support for the entourage effect, the theory that cannabinoids enhance each other. It is still only a theory, however, and the study was not designed to prove it. You can read more about how the two compounds differ in our article on CBD and THC.

A 2026 systematic review that pulled together several trials of cannabinoids for pain reached similar conclusions: the THC and CBD combination worked for migraine, while CBD on its own did not. The review also noted that products containing THC caused more psychoactive side effects.

In most European countries, THC-rich cannabis is either prohibited or available only on prescription, so this is not a treatment most people can use. Above all, the study adds to what we know about how different cannabinoids affect the body during acute pain.

What did the study show about THC and CBD for migraine?

The combination of 6% THC and 11% CBD gave more pain relief than placebo two hours after treatment, and more participants became completely pain-free. For many, the effect lasted up to 48 hours.

Did CBD on its own help with migraine in the study?

No. The CBD-dominant type did not differ from placebo on any of the main measures.

How many people took part in the study?

92 adults with migraine took part, treating a total of 247 migraine attacks.

Were there any side effects?

No serious side effects were reported. A 2026 review did, however, note that products containing THC caused more psychoactive side effects than placebo.

Can the results be used as medical advice?

No. This article summarises research and should not replace medical advice. Always talk to a healthcare professional about migraine treatment.

This article summarises scientific research and is intended for general information only. It is not medical advice and should not be used to make a diagnosis or choose a treatment. Always consult a doctor or other healthcare professional.

Sources

From the article
Scroll to Top